Free tool · No account
Clinical trials for kidney cancer
Kidney cancer (renal cell carcinoma) trials often combine immunotherapy with targeted drugs. Which fit depends on the subtype and whether the cancer has spread.
404 recruiting trials. Showing a sample.
- recruitingPhase 1NCT06910657
IDOV-Immune for Advanced Solid Tumors
This is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not responded to standard treatments. Oncolytic viruses are designed to infect and destroy cancer cel...
Listed by the study for Renal Cell Carcinoma. Record updated 2026-08-05.
Sponsored by ViroMissile, Inc.Full details on ClinicalTrials.gov → - recruitingNANCT07767500
Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer
The purpose of this study is to investigate the use of an MR-guided linear accelerator to treat early stage renal cancer patients, considered inoperable or in patients declining surgerys. The study will collect efficacy, toxicity, and dosimetry data and assess the degree of im...
Listed by the study for Primary Renal Cancer. Record updated 2026-08-21.
Sponsored by NYU Langone HealthFull details on ClinicalTrials.gov → - recruitingEARLY_Phase 1NCT07671417
Imaging Study in Metastatic Clear Cell RCC.
This imaging study aims to assess the feasibility, biodistribution, and dosimetry of the imaging agent in Subjects with Metastatic Clear Cell Renal Cell Cancer (RCC).
Listed by the study for Metastatic Clear Cell Renal Cell Carcinoma. Record updated 2026-09-29.
Sponsored by RayzeBio, Inc.Full details on ClinicalTrials.gov → - recruitingPhase 1NCT07128680
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
This phase I trial tests the safety and effectiveness of nivolumab and ipilimumab with and without EXL01 for the treatment of renal cell cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Immunotherapy with monoclonal an...
Listed by the study for Advanced Clear Cell Renal Cell Carcinoma. Record updated 2026-07-16.
Sponsored by City of Hope Medical CenterFull details on ClinicalTrials.gov → - recruitingPhase 1NCT05536141
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
The purpose of this study is to evaluate the safety and tolerability of: * casdatifan when taken alone in participants with advanced solid tumor malignancies and clear cell renal cell carcinoma (ccRCC) during the dose escalation stage; and * casdatifan monotherapy and casdati...
Listed by the study for Clear Cell Renal Cell Carcinoma. Record updated 2026-10-05.
Sponsored by Arcus Biosciences, Inc.Full details on ClinicalTrials.gov → - recruitingNCT06956144
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
To evaluate the efficacy of targeted CAIX-specific probe PET imaging in the diagnosis and staging of kidney cancer, as well as to assess its role in prognosis prediction and treatment evaluation for kidney cancer.
Listed by the study for Kidney Neoplasms. Record updated 2025-05-29.
Sponsored by The First Affiliated Hospital of Xiamen UniversityFull details on ClinicalTrials.gov → - recruitingPhase 1NCT06819293
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
This is an open label, single center, dose escalation, and dose extension IIT study aimed at evaluating the safety, efficacy, and pharmacokinetics of IB-T101 in adult patients with advanced clear renal cell carcinoma
Listed by the study for Advanced Clear Renal Cell Carcinoma. Record updated 2026-04-14.
Sponsored by Grit BiotechnologyFull details on ClinicalTrials.gov → - recruitingNCT05231655
Ex VIvo DEtermiNed Cancer Therapy
EVIDENT's aim is to test if ex vivo drug screening can predict whether patients with solid cancers will respond, or not respond, to standard care treatments. Patients undergoing standard care surgery to excise their tumour, those undergoing a biopsy, or those having a fluid as...
Listed by the study for Kidney Cancer. Record updated 2025-02-24.
Sponsored by Sheffield Teaching Hospitals NHS Foundation TrustFull details on ClinicalTrials.gov → - recruitingPhase 1, Phase 2NCT07410676
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
This Phase 1/2 study evaluates the safety, tolerability, and preliminary anti-tumor activity of EBNK-001 (allogeneic NK cells) given after lymphodepleting cyclophosphamide/fludarabine (CY/FLU) and supported with low-dose IL-15, administered either alone or in combination with ...
Listed by the study for Kidney Cancer. Record updated 2026-02-18.
Sponsored by Essen BiotechFull details on ClinicalTrials.gov → - recruitingNANCT06572501
Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position
The goal of this clinical trial is to investigate whether robot-assisted laparoscopic partial nephrectomy by extraperitoneal approach in the prone position had any advantages over the traditional lateral position. The main questions it aims to answer are: Is prone surgery saf...
Listed by the study for Carcinoma, Renal Cell. Record updated 2024-08-27.
Sponsored by The First Affiliated Hospital with Nanjing Medical UniversityFull details on ClinicalTrials.gov →
Data from ClinicalTrials.gov, retrieved 2026-10-12. Study sponsors write and update their own records there, including the recruitment status shown here, and the U.S. government does not review or approve every study listed. A trial showing up here is not a recommendation and not a determination that anyone qualifies. Eligibility is decided by the trial's own doctors.
Refine for your situation
Add whatever you know: an age, a city, a mutation from a pathology report. We'll narrow the list to trials that fit. Describe it in your own words.
Trials for other conditions
What we will never do with your records
This generator runs without an account, and KeptWell itself makes the same promises to every family, regardless of plan or price.
- We won't sell your data.
- Not to advertisers, not to data brokers, not to insurers, not to pharma, not to anyone, in any form, ever.
- We won't train AI models on your records.
- KeptWell does not opt in to model training. OpenAI and Anthropic do not use API inputs or outputs to train their models by default.
- We won't lock you in.
- You can export everything in your circle as a ZIP at any time. Cancellation is one click.
Common questions
- Is this kidney cancer trial finder really free?
- Yes. You describe the situation, we search ClinicalTrials.gov and show what matches. No account, no payment, no email required. Nothing you type is saved.
- Does showing up here mean the patient qualifies?
- No. A listing here is not a recommendation, and the U.S. government does not review or approve every study on ClinicalTrials.gov. These are trials worth asking your care team about. Every trial has detailed eligibility criteria that the trial's own doctors evaluate, and many depend on test results and treatment history that only your medical team knows in full.
- How current is this list?
- The trials come directly from ClinicalTrials.gov and are refreshed daily, with the retrieval date shown under the list. Each study record is written and kept up to date by that study's own sponsor, so the recruitment status is what the sponsor last reported. Each result links to the full, live record, and the finder above always runs a fresh search when you use it.
- What should I do with a trial that looks promising?
- Bring it to your oncologist or care team, and mention the NCT number (the ID that starts with NCT). They can tell you whether it is a genuine fit and refer you to the trial site.
Found trials worth discussing? Keep them next to the records.
The next step is a conversation with the care team, and that goes better when the scans, labs, and trial details live in one place everyone in the family can see. That's what KeptWell is: the binder, but it understands what's inside.
Get started
We'll email you a secure sign-in link. It works whether you're new here or already have an account.